CEO Andrew Dudum maintains 9.4% stake in Hims & Hers Health, Inc

What did Hims & Hers Health, Inc. announce?

Andrew Dudum, CEO, beneficially owns 9.4% of Hims & Hers Health, Inc. Class A Common Stock, as an amendment to a previously filed Schedule 13D.

Key details

• Andrew Dudum beneficially owns 22,610,002 shares of Class A Common Stock.
• This represents 9.4% of the outstanding Class A Common Stock, assuming conversion and exercise of all holdings.
• Mr. Dudum is the Chief Executive Officer and a director of the Issuer.

Why it matters

This 13D/A reports a change in ownership at Hims & Hers Health, Inc.. The likely share-price reaction reads as neutral.

More from Hims & Hers Health, Inc.

• 4

  Sep 18, 2026
  CFO Oluyemi Okupe sells 12,313 shares for $354,861
• 4

  Sep 17, 2026
  Chief Legal Officer sells 6,236 shares for $173,735
• 4

  Sep 17, 2026
  COO Michael Chi sells 14,027 shares for $398K under 10b5-1 plan
• 4

  Sep 17, 2026
  CTO Mohamed Elshenawy sells 7,954 shares for $226K
• 4

  Sep 3, 2026
  Chief Legal Officer sells $97,965 of stock under 10b5-1 plan

All Hims & Hers Health, Inc. SEC filings →